questionsmedicales.fr
Maladies métaboliques et nutritionnelles
Maladies métaboliques
Troubles du métabolisme du fer
Surcharge en fer
Hémosidérose
Hémosidérose : Questions médicales fréquentes
Diagnostic
5
Ferritine
Transferrine
Hémosidérose
Imagerie par résonance magnétique
Fer
Hémosidérose
Symptômes
Hépato-splénomégalie
Hémosidérose
Biopsie
Foie
Hémosidérose
Symptômes
5
Symptômes
Fatigue
Hémosidérose
Douleur
Hémosidérose
Articulations
Pigmentation
Peau
Hémosidérose
Troubles cardiaques
Arythmies
Hémosidérose
Foie
Hépatomégalie
Hémosidérose
Prévention
5
Prévention
Transfusions sanguines
Fer
Surveillance
Métabolisme du fer
Hémosidérose
Alimentation
Fer
Hémosidérose
Compléments alimentaires
Fer
Hémosidérose
Traitements
5
Chélation
Fer
Hémosidérose
Phlébotomie
Fer
Hémosidérose
Déférasirox
Médicaments
Hémosidérose
Diète
Chélation
Hémosidérose
Suivi médical
Fer
Hémosidérose
Complications
5
Complications
Maladies hépatiques
Hémosidérose
Diabète
Endocrinologie
Hémosidérose
Cardiomyopathie
Arythmies
Hémosidérose
Douleurs articulaires
Articulations
Hémosidérose
Facteurs de risque
5
Facteurs de risque
Transfusions sanguines
Métabolisme du fer
Hémochromatose
Hérédité
Hémosidérose
Alcool
Métabolisme du fer
Hémosidérose
Maladies chroniques
Facteurs de risque
Hémosidérose
Personnes âgées
Facteurs de risque
Hémosidérose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémosidérose : Questions médicales les plus fréquentes",
"headline": "Hémosidérose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémosidérose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-23",
"dateModified": "2026-05-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémosidérose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Surcharge en fer",
"url": "https://questionsmedicales.fr/mesh/D019190",
"about": {
"@type": "MedicalCondition",
"name": "Surcharge en fer",
"code": {
"@type": "MedicalCode",
"code": "D019190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hémosidérose",
"alternateName": "Hemosiderosis",
"code": {
"@type": "MedicalCode",
"code": "D006486",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Biplab K Saha",
"url": "https://questionsmedicales.fr/author/Biplab%20K%20Saha",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, MO, USA. Electronic address: spanophiliac@yahoo.com."
}
},
{
"@type": "Person",
"name": "Alyssa Bonnier",
"url": "https://questionsmedicales.fr/author/Alyssa%20Bonnier",
"affiliation": {
"@type": "Organization",
"name": "Department of Critical Care Nursing, Goldfarb School of Nursing, Barnes Jewish College, St. Louis, Missouri, USA."
}
},
{
"@type": "Person",
"name": "Santu Saha",
"url": "https://questionsmedicales.fr/author/Santu%20Saha",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Saha Clinic, Narail, Bangladesh."
}
},
{
"@type": "Person",
"name": "Nils T Milman",
"url": "https://questionsmedicales.fr/author/Nils%20T%20Milman",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Biochemistry, Næstved Hospital, University College Zealand, Næstved, Denmark."
}
},
{
"@type": "Person",
"name": "Alexis Aiman",
"url": "https://questionsmedicales.fr/author/Alexis%20Aiman",
"affiliation": {
"@type": "Organization",
"name": "New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Arkansas, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Early Initiation of Steroid-sparing Drugs in Idiopathic Pulmonary Hemosiderosis.",
"datePublished": "2019-01-15",
"url": "https://questionsmedicales.fr/article/30806370",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Autoimmunity and Delayed Diagnosis in Pediatric Idiopathic Pulmonary Hemosiderosis.",
"datePublished": "2020-05-00",
"url": "https://questionsmedicales.fr/article/31107369",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MPH.0000000000001513"
}
},
{
"@type": "ScholarlyArticle",
"name": "Respiratory Distress and Severe Anemia in a Child With Idiopathic Pulmonary Hemosiderosis.",
"datePublished": "2019-May-00",
"url": "https://questionsmedicales.fr/article/29683951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MPH.0000000000001175"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liposteroid Therapy for Idiopathic Pulmonary Hemosiderosis: A Scoping Review of the Literature.",
"datePublished": "2022-00-00",
"url": "https://questionsmedicales.fr/article/35507939",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14712/23362936.2022.7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Axillary Cutaneous Hemosiderosis in a Patient With Hyperhidrosis, After Intravenous Iron Infusion.",
"datePublished": "2023-Jul-01",
"url": "https://questionsmedicales.fr/article/37249371",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DAD.0000000000002461"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles du métabolisme du fer",
"item": "https://questionsmedicales.fr/mesh/D019189"
},
{
"@type": "ListItem",
"position": 5,
"name": "Surcharge en fer",
"item": "https://questionsmedicales.fr/mesh/D019190"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hémosidérose",
"item": "https://questionsmedicales.fr/mesh/D006486"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémosidérose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémosidérose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémosidérose",
"description": "Comment diagnostique-t-on l'hémosidérose ?\nQuels tests sanguins sont utilisés ?\nL'IRM peut-elle aider au diagnostic ?\nQuels signes cliniques sont observés ?\nUne biopsie est-elle nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémosidérose",
"description": "Quels sont les symptômes courants de l'hémosidérose ?\nL'hémosidérose cause-t-elle des douleurs ?\nY a-t-il des symptômes cutanés ?\nPeut-on avoir des troubles cardiaques ?\nL'hémosidérose affecte-t-elle le foie ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémosidérose",
"description": "Comment prévenir l'hémosidérose ?\nLes personnes à risque doivent-elles être surveillées ?\nUne alimentation spécifique peut-elle aider ?\nLes compléments de fer doivent-ils être évités ?\nLes tests de fer sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémosidérose",
"description": "Quels traitements sont disponibles pour l'hémosidérose ?\nLa phlébotomie est-elle une option ?\nQuels médicaments sont utilisés ?\nY a-t-il des traitements alternatifs ?\nLe suivi médical est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémosidérose",
"description": "Quelles complications peuvent survenir ?\nL'hémosidérose peut-elle causer un cancer ?\nY a-t-il un risque de diabète ?\nComment l'hémosidérose affecte-t-elle le cœur ?\nDes problèmes articulaires peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémosidérose",
"description": "Quels sont les principaux facteurs de risque ?\nLes maladies héréditaires augmentent-elles le risque ?\nL'alcool joue-t-il un rôle ?\nLes maladies chroniques sont-elles un facteur ?\nLes personnes âgées sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D006486#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'hémosidérose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, biopsies et imageries pour évaluer le fer."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la ferritine sérique et la saturation de la transferrine."
}
},
{
"@type": "Question",
"name": "L'IRM peut-elle aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM peut détecter l'accumulation de fer dans les organes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, douleurs abdominales et troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Une biopsie est-elle nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie du foie peut être réalisée pour confirmer l'accumulation de fer."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hémosidérose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs articulaires, et troubles digestifs."
}
},
{
"@type": "Question",
"name": "L'hémosidérose cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs abdominales et articulaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépôts de fer peuvent entraîner une pigmentation cutanée anormale."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles cardiaques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de fer peut affecter le cœur, entraînant des arythmies."
}
},
{
"@type": "Question",
"name": "L'hémosidérose affecte-t-elle le foie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer une hépatomégalie et des troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hémosidérose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les transfusions sanguines inutiles et surveiller les niveaux de fer."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des troubles du métabolisme du fer doivent être suivies."
}
},
{
"@type": "Question",
"name": "Une alimentation spécifique peut-elle aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduire les aliments riches en fer peut aider à prévenir l'accumulation."
}
},
{
"@type": "Question",
"name": "Les compléments de fer doivent-ils être évités ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les compléments de fer doivent être évités sans avis médical."
}
},
{
"@type": "Question",
"name": "Les tests de fer sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers des niveaux de fer sont conseillés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hémosidérose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la chélation du fer pour réduire son accumulation."
}
},
{
"@type": "Question",
"name": "La phlébotomie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la phlébotomie peut être utilisée pour réduire les niveaux de fer dans le sang."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents chélateurs comme la déférasirox sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches diététiques peuvent aider, mais la chélation est plus efficace."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les niveaux de fer."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies hépatiques, cardiaques et endocriniennes."
}
},
{
"@type": "Question",
"name": "L'hémosidérose peut-elle causer un cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation excessive de fer peut augmenter le risque de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hémosidérose peut entraîner des troubles endocriniens, y compris le diabète."
}
},
{
"@type": "Question",
"name": "Comment l'hémosidérose affecte-t-elle le cœur ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des cardiomyopathies et des arythmies cardiaques."
}
},
{
"@type": "Question",
"name": "Des problèmes articulaires peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de fer peut entraîner des douleurs et des dommages articulaires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les transfusions sanguines fréquentes et les troubles génétiques du métabolisme du fer."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'hémochromatose augmentent le risque d'hémosidérose."
}
},
{
"@type": "Question",
"name": "L'alcool joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation excessive d'alcool peut aggraver l'accumulation de fer."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent augmenter le risque d'hémosidérose."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hémosidérose augmente avec l'âge en raison de l'accumulation de fer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/05/2026
Contenu vérifié selon les dernières recommandations médicales
12 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, MO, USA. Electronic address: spanophiliac@yahoo.com.
7 publications dans cette catégorie
Affiliations :
Department of Critical Care Nursing, Goldfarb School of Nursing, Barnes Jewish College, St. Louis, Missouri, USA.
6 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Saha Clinic, Narail, Bangladesh.
6 publications dans cette catégorie
Affiliations :
Department of Clinical Biochemistry, Næstved Hospital, University College Zealand, Næstved, Denmark.
3 publications dans cette catégorie
Affiliations :
New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Arkansas, USA.
Publications dans "Hémosidérose" :
3 publications dans cette catégorie
Affiliations :
Department of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY, USA.
Publications dans "Hémosidérose" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Saha Clinic, Narail, Bangladesh.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany. artukarslan.eralp-niyazi@mh-hannover.de.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Neuroradiology, Hannover Medical School, Hannover, Germany.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Japan.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatric Cardiology, Saitama Children's Medical Center, Saitama, Japan.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Neurosurgery, Sapporo Medical University.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Neurosurgery, Sapporo Medical University.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Neurosurgery, Sapporo Medical University.
Publications dans "Hémosidérose" :
1 publication dans cette catégorie
Affiliations :
Department of Neurosurgery, Sapporo Medical University.
Publications dans "Hémosidérose" :
Idiopathic pulmonary hemosiderosis is conventionally treated with steroids, prolonged usage of which maybe deleterious and disease often recurs on tapering. We initiated hydroxy-chloroquine and azathi...
Idiopathic pulmonary hemosiderosis is characterized by a triad of iron-deficiency anemia, hemoptysis, and radiographic diffuse lung infiltrates. However, the inconsistent initial presentation in child...
Idiopathic pulmonary hemosiderosis is an infrequent cause of pulmonary hemorrhage in children. It is classically defined by the triad of recurrent hemoptysis, iron-deficiency anemia, and diffuse paren...
Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of diffuse alveolar hemorrhage (DAH). Glucocorticosteroids (CS) represent the first line therapy for IPH. Although most patients respond to CS,...
Hemosiderosis consists of an iron deposit in tissues, which does not cause organic damage to them. However, in the case of the skin, being an organ exposed to sight, siderosis can produce a brownish c...
The idiopathic pulmonary hemosiderosis is a rare, life-threatening condition observed mainly in children and characterized by recurrent episodes of diffuse alveolar hemorrhages. The disease is charact...
The study evaluates the long-term deferasirox treatment of adult and pediatric patients with chronic transfusional iron overload in clinical practice....
In this non-interventional study, patients were observed for up to 3 years from initiation of deferasirox treatment both prospectively and retrospectively for up to 1 year prior to enrollment. The pri...
Overall, 120 patients were enrolled and 51 completed the study, with a limited 3-year dropout rate of 12.5% due to adverse events (AEs). Increase in SCr > 33% above baseline and the age-adjusted ULN (...
The long-term treatment with deferasirox was manageable in most transfusion-dependent patients with no unexpected safety findings. Regular monitoring and an adjusted deferasirox dosing strategy per lo...
The aim of this study was to evaluate the vitamin D-PTH axis in thalassemia major (TM) in relation to hepatic siderosis liver iron content....
In this case-controlled observational study, vitamin D-PTH axis was studied in 158 TM and 84 age and ethnicity-matched healthy nonthalassemic controls attending University College Hospital, London. Pa...
In TM, 25-OHD insufficiency was 8-fold higher than the control group (odds ratio [OR], 8.1; 95% confidence interval [CI], 4.3-15.0; P<0.001). Similarly, serum PTH (P<0.001), calcium (P<0.001), and pho...
Our results suggest that TM had a 8-fold higher risk of 25-OHD insufficiency compared with the controls. This was likely to be associated with hepatic hemosiderosis....
Renal hemosiderosis is a disease in which hemosiderin deposits in the renal cortex as a form of iron overload. However, cases of renal hemosiderosis due to intravascular hemolysis following mitral val...
We present the case of a 62-year-old woman who developed asymptomatic urinary abnormalities including microscopic hematuria and proteinuria due to renal hemosiderosis following a mitral valve repair s...
A percutaneous renal biopsy showed no specific glomerular abnormality, tubular atrophy, or interstitial fibrosis but extensive deposition of hemosiderin in the proximal tubule. The patient was diagnos...
Our patient refused a mitral valve repeat surgery and hence was treated with oral iron preparations, N-acetylcysteine, and a β-receptor blocker....
Moderate mitral regurgitation with the regurgitant blood striking against the annuloplasty ring was confirmed on follow-up echocardiography. After the 24-month follow-up period, hemolytic anemia persi...
For cases of chronic intravascular hemolysis accompanied with asymptomatic urinary abnormalities, a renal biopsy is required to exclude underlying kidney pathology and predict potential renal insuffic...
This study aims to review the clinical characteristics, therapeutic response and outcome of idiopathic pulmonary hemosiderosis (IPH), and discover the risk factors for recurrence in children with IPH,...
Children with a diagnosis of IPH were enrolled in the study. Clinical data of the children were collected and analysed....
A total of 32 patients with regular follow-up after diagnosis were included in this study. Anaemia, cough and haemoptysis constituted the most common initial symptoms of the disease, and the incidence...
Cough and anaemia are the most common symptoms in children with IPH. The recurrence rate of this disease is high, and respiratory tract infection is the most common cause of its recurrence. High-dose ...
This study is a retrospective and observational study, which does not involve human specimens or clinical intervention. Therefore, clinical trial registration is not required, and there is no clinical...